Federal Pact Lifts Drug Firm ; Human Genome Sciences Sells Anthrax Treatment

The Washington Times › October 04, 2005

Linked as:

Summary

Shares of Human Genome Sciences Inc. rose more than 3 percent yesterday after the Rockville drug company announced a contract to supply the federal government with medicine to treat anthrax.

Human Genome will supply 10 grams of the drug, ABthrax, to the Department of Health and Human Services for testing for $1.8 million under terms of the company's first contract.

See the full content of this document

Extract

Federal Pact Lifts Drug Firm ; Human Genome Sciences Sells Anthrax Treatment

The department has the option to buy up to 100,000 doses of the drug for an undisclosed amount. The medicine would be stored in the Strategic...

See the full content of this document